Complement-dependent cytolytic anti-Trichomonas vaginalis monoclonal antibodies
US5004694A · kind A · utility
7Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 1987 |
| Grant date | Apr 2, 1991 |
| Priority date | — |
| Expiry date | Sep 4, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/861
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel monoclonal antibodies specific to Trichomonas vaginalis, having complement--fixing ability and lysing Trichomonas vaginalis in the presence of complement are disclosed and may be used in therapy and diagnosis of trichomoniasis. Hybridomas producing and compositions comprising these antibodies are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.